Fair Money & Economic Opportunity

Zimmer Biomet Holdings Inc. operates in the healthcare equipment industry, manufacturing and marketing orthopedic products.

The company does not offer lending, deposit, or other financial services to consumers or businesses. Therefore, all Key Performance Indicators related to financial products, pricing, customer financial data, lending practices, and financial literacy initiatives are not applicable to its core business model. While the company engages in diversity, equity, and inclusion efforts and community support through its foundation, these activities do not involve financial services or microloans as defined by the "Fair Money & Economic Opportunity" value.

Fair Pay & Worker Respect

Zimmer Biomet's CEO total compensation was 220 times the median employee's pay in 2024, an improvement from 250:1 in the prior year.

The company reported a Total Recordable Incident Rate (TRIR) of 0.23 and a Lost Time Incident Rate (LTIR) of 0.13 in 2023. Additionally, it achieved a 100% rating on the 2022 Corporate Equality Index, indicating excellence in non-discrimination policies and equitable employment benefits for LGBTQ+ workers.

Fair Trade & Ethical Sourcing

Zimmer Biomet conducts Social Responsibility audits every three years for existing suppliers in high-risk regions and all new suppliers.

These audits investigate issues such as child labor, forced labor, and human trafficking. In 2022, 30 suppliers were audited, identifying two major findings that have since been remediated. The company's Supplier Code of Conduct, updated in 2022 and distributed to all suppliers, includes a zero-tolerance policy for child and forced labor. In 2023, 16% of Zimmer Biomet's U.S. supplier spend was directed to U.S. suppliers in designated diversity categories.

Honest & Fair Business

Zimmer Biomet has implemented comprehensive anti-bribery and anti-corruption policies, a code of business conduct, training programs, and regular audits

. The company also provides a speak-up hotline . In 2023, it reported zero pending FDA Warning Letters and maintained under 10 product recalls for the second consecutive year . Historically, the company settled FCPA violations in 2012 and 2017 , and a 2024 qui tam action alleged Anti-Kickback Statute violations .

Kind to Animals

Zimmer Biomet has a comprehensive animal testing policy, adhering to the principles of Replace, Reduce, and Refine.

Animal testing is only utilized when required to demonstrate biological safety for products that cannot be demonstrated by laboratory benchtop tests or to comply with medical device regulations. The company does not perform animal testing directly, but contracts it to approved laboratories. Zimmer Biomet uses advanced technologies such as computer modeling and simulation to help replace the use of animals in research and testing. In its supply chain, 87% of Tier 1 suppliers are audited by a third-party as of 2023. For wildlife conservation, Zimmer Biomet has been a corporate sponsor of ACRES Land Trust since 2011, which protects over 7,200 acres across more than 115 nature preserves. The company has also transformed 25 acres of its own maintained grass property in Warsaw, Indiana, into a native habitat for indigenous plants, supporting pollinators and birds. The company has also leased a 12,000-square-meter area in Taiwan for tree planting.

No War, No Weapons

Zimmer Biomet Holdings Inc. is a medical technology company that does not manufacture weapons or engage directly in military activities. Its primary business focuses on healthcare and medical devices. The company has contracts with the U.S. Department of Defense to supply medical devices, including a $48,895,527 contract for spinal supplies awarded in February 2023

and a $381 million contract for orthopedic products awarded in April 2016 . As the company does not manufacture weapons, it has no exposure to controversial or banned weapons, nor does it require ethical red lines for weapons. It also has no defense assets to divest.

Planet-Friendly Business

Zimmer Biomet has SBTi-approved Net-Zero greenhouse gas emissions targets for 2050

, which include an interim goal to cut Scope 1 and 2 emissions by 50% by 2030 . The company reduced its Scope 1 and 2 market-based carbon emissions by over 7% in 2023 compared to 2022 , with these emissions totaling 187,500 metric tons CO₂e in 2022 . Its North American electrical load is 100% offset by a solar farm . The company expanded its Zero Waste to Landfill program, achieving internal certification for 18 sites globally . It also reduced total waste generation by 25.3% and water usage by 18.2% since 2019, and improved energy efficiency by 22.7% . Surgical instrument packaging has 68% recyclability .

Respect for Cultures & Communities

The Zimmer Biomet Foundation donated up to $2.5 million for the renovation of the Center Lake Pavilion in Warsaw, Indiana, a historical community hub built in 1935.

This project demonstrates the company's commitment to supporting local heritage and community infrastructure.

Safe & Smart Tech

Zimmer Biomet demonstrates a transformative approach to vulnerability management, applying critical patches as soon as the day of discovery for some solutions.

The company maintains an exemplary regulatory compliance program, adhering to a wide range of global privacy regulations including HIPAA, GDPR, CCPA, LGPD, PIPL, APEC CBPR, and EU-U.S. DPF, with compliance reviewed and verified by third-party experts and monitored through annual recertifications. Its privacy certifications are comprehensive, including ISO 27001 for its Surgery Planning Ecosystem , ISO 13485, and MDSAP for principal manufacturing sites , alongside APEC CBPR and DPF compliance. Users are provided excellent control over their personal data, with rights such as access, portability, correction, deletion, restriction, objection, and consent revocation , supported by tools and processes to facilitate their exercise. The company has strong data governance, preventing unauthorized data use , and has established a formal Coordinated Vulnerability Disclosure (CVD) channel for security researchers.

Zero Waste & Sustainable Products

Zimmer Biomet achieved a 77% waste diversion rate in 2024, with 65% recycled

and 12% sent to waste-to-energy facilities. The company has 21 sites internally certified as Zero Waste to Landfill (ZWTL) in 2024, representing 58% of its in-scope global network, with ZWTL status requiring at least 85% waste diversion. The ZWTL program has a goal of sending no waste directly to landfill for disposal. In 2022, total waste generation was reduced by 25.3% compared to a 2019 baseline, supported by a $12.7 million investment in environmental sustainability initiatives. However, the company reported no products accepted for takeback and reuse, recycling, or donation.